Summary by Moomoo AI
EC Healthcare released its annual report and business review for the year ending March 31, 2024. During the year, the company achieved a revenue of HKD 4211.034 million. EC Healthcare's business covers Hong Kong, Macau and mainland China. The company's dividend policy includes that the final dividend must be approved by shareholders to confirm the debt, while the interim dividend is confirmed immediately upon proposal and declaration. In addition, the company operates stock option plans and stock incentive plans, and includes share-based payment expenses in employee costs. Regarding shareholder rights, the final dividend requires approval from shareholders, while the board of directors has the power to declare interim dividends. Major risks and uncertainties include impairment of goodwill and non-financial...Show More